TRXADE HEALTH INC (MEDS) Stock Analyst Ratings
NASDAQ:MEDS - Nasdaq - US89846A4058 - Common Stock - Currency: USD
ChartMill assigns a Buy % Consensus number of 83% to MEDS. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 6.89. This target is -9.29% below the current price.
MEDS was analyzed by 7 analysts. The buy percentage consensus is at 83. So analysts seem to be very confident about MEDS.
In the previous month the buy percentage consensus was at a similar level.
MEDS was analyzed by 7 analysts. More opinions would make the average more meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2023-05-16 | EF Hutton | Maintains | Buy -> Buy |
| 2023-03-28 | Maxim Group | Maintains | Buy |
| 2021-12-09 | EF Hutton | Initiate | Buy |